Nucleic acids created solely by synthetic means will be covered by National Institutes of Health guidelines on research using recombinant DNA under final revisions announced in a Sept. 5 Federal Register notice, but the new guidelines will not expand review of studies involving the deliberate introduction of drug resistance into microorganisms, as had been proposed (
With this revision, NIH took final action on a process that began in March 2009, when the agency proposed to update the NIH guidelines on research using recombinant DNA (
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.